<DOC>
	<DOCNO>NCT01404182</DOCNO>
	<brief_summary>The purpose study determine immunogenicity tolerability Fluval AB trivalent influenza vaccine adult elderly people .</brief_summary>
	<brief_title>Tolerability Immunogenicity Study Fluval AB Influenza Vaccine Adults Elderly Persons</brief_title>
	<detailed_description>Immunogenicity Objective : To assess immunogenicity single intramuscular ( IM ) injection Fluval AB influenza vaccine ( trivalent , seasonal , active ingredient content : 15 μg HA/0.5mL seasonal H1N1 , H3N2 B influenza antigen ) , measure haemagglutination inhibition ( HI ) test . Safety Tolerability Objectives : To evaluate safety tolerability ( incidence adverse event ) single intramuscular ( IM ) injection Fluval AB influenza vaccine ( trivalent , seasonal , active ingredient content : 15 μg HA/0.5mL ) .</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Aluminum phosphate</mesh_term>
	<criteria>Adults age 18 60 year , elderly person age 60 year , sex , mentally competent Are good health ( determine vital sign exist medical condition ) stable medical condition . Subjects exclude know adequately treat clinically significant organ systemic disease ( e.g . asthma diabetes ) , , opinion investigator , significance disease compromise subject 's participation study Female volunteer age 1860 year ( i.e . participant childbearing potential ) negative result urine pregnancy test prior vaccination agree use acceptable contraception method abstinence throughout trial become pregnant duration study . Capability participant understand comply plan study procedure Participants age 18 year provide write informed consent prior initiation study procedure Absence existence exclusion criterion . Pregnancy , breast feeding positive urine pregnancy test baseline prior vaccination . Female subject able bear child willing use acceptable contraception method duration study . Known hypersensitivity egg , chicken protein , thiomersal , formaldehyde , gentamycin , ciprofloxacin , neomycin component vaccine History GuillainBarré syndrome History neurological symptom sign , anaphylactic shock follow administration vaccine Serious disease , cancer , autoimmune disease , advance arteriosclerotic disease , complicate diabetes mellitus , acute progressive hepatic disease , acute progressive renal disease , congestive heart failure Immunosuppressive therapy within past 36 month Concomitant corticosteroid therapy , include highdose inhaled corticosteroid Receipt immunostimulants , Receipt parenteral immunoglobulin , blood product and/or plasma derivate within past 3 month Suspected HIV , HBV HCV infection Acute disease and/or axillary temperature ≥37oC within past 3 day Vaccine therapy within past 4 week Influenza vaccination ( kind ) within past 6 month Experimental drug therapy within past 4 week Concomitant participation another clinical study Any condition , opinion investigator , may interfere evaluation study Past current psychiatric disease volunteer upon judgement investigator may effect objective decisionmaking volunteer Alcohol drug abuse participant .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>seasonal</keyword>
	<keyword>prevention</keyword>
	<keyword>influenza</keyword>
	<keyword>infection</keyword>
	<keyword>influenza vaccine</keyword>
	<keyword>vaccine</keyword>
	<keyword>influenza human</keyword>
</DOC>